Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

PathoGenesis begins clinical trial of TOBI in patients with severe bronchiectasis

July 4, 2000

AWD-12-343 compares favorably with known PDE4 inhibitors in model of lung inflammation

June 30, 2000

Selective PDE4 inhibitors with bronchodilating, antiinflammatory properties

June 29, 2000

United Therapeutics discontinues UT-77 development project

June 28, 2000

Use of seratrodast for COPD supported by clinical results

June 28, 2000

Roche presents 4-aroylpiperidines active as chemokine receptor antagonists

June 28, 2000

Icos acquires additional rights to Abbott's LFA-1 compounds

June 27, 2000

F-1322 dropped from development after reaching phase II

June 27, 2000

Eotaxin found to regulate gastrointestinal allergic reactions

June 27, 2000

Additive or synergistic effects of surfactant and PDE4 inhibitor in acute lung injury

June 26, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...